Koers Chempartner Pharmatech Co., Ltd.
Aandelen
300149
CNE100000Y27
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,73 CNY | +1,94% | +1,07% | -38,17% |
2023 | Chempartner Pharmatech Co, Ltd. Rapporteert winstresultaten voor de negen maanden eindigend op 30 september 2023 | CI |
2023 | ChemPartner PharmaTech CFO stapt op | MT |
Omzet 2021 | 1,69 mld. 233 mln. 218 mln. | Omzet 2022 | 1,33 mld. 183 mln. 171 mln. | Marktkapitalisatie | 5,18 mld. 715 mln. 668 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -402 mln. -55,48 mln. -51,82 mln. | Nettowinst (verlies) 2022 | 379 mln. 52,31 mln. 48,86 mln. | EV/omzet 2021 | 5 x |
Nettoschuld 2021 | 1,57 mld. 216 mln. 202 mln. | Nettoschuld 2022 | 205 mln. 28,23 mln. 26,37 mln. | EV/omzet 2022 | 4,06 x |
K/w-verhouding 2021 |
-17
x | K/w-verhouding 2022 |
13,7
x | Werknemers | 2.072 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 23,15% |
1 dag | +1,94% | ||
1 week | +1,07% | ||
Lopende maand | -14,31% | ||
1 maand | -19,56% | ||
3 maanden | -23,21% | ||
6 maanden | -40,88% | ||
Lopend jaar | -38,17% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ji Guo Zhang
CEO | Chief Executive Officer | 51 | 08-02-23 |
Yin Qun Cha
DFI | Director of Finance/CFO | 45 | 08-10-23 |
Hong Hui Li
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xin Hui
BRD | Director/Board Member | 53 | 01-08-18 |
Chi Shing Kwok
BRD | Director/Board Member | 62 | 12-10-20 |
Xian Zhong Wang
BRD | Director/Board Member | 54 | 23-08-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 4,73 | +1,94% | 6 408 600 |
23-04-24 | 4,64 | +4,98% | 7 492 060 |
22-04-24 | 4,42 | -5,35% | 6 461 162 |
19-04-24 | 4,67 | 0,00% | 7 498 727 |
18-04-24 | 4,67 | -0,21% | 8 648 319 |
slotkoers Shenzhen S.E., 24 april 2024
Meer koersenWinst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-38,17% | 319 mln. | |
+4,09% | 43,43 mld. | |
+47,81% | 41,69 mld. | |
+9,45% | 41,31 mld. | |
-10,92% | 27,14 mld. | |
+9,32% | 25,28 mld. | |
-24,87% | 18,47 mld. | |
+29,70% | 12,59 mld. | |
+1,28% | 12,33 mld. | |
+7,78% | 11,03 mld. |